Page results
-
What to expect from your neuro-oncology Clinical Nurse Specialist (key worker) at the NHNN
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
This leaflet has written by the administration team at the National Hospital for Neurology and Neurosurgery for outpatients.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
SUMMIT Study results on the benefits of large-scale screening for lung cancer are published in The Lancet Oncology today (26 March), ahead of the formal addition of lung cancer screening to the UK national screening programme from 1 April.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Patients waiting for an appointment or worrying about a diagnosis will be inspired by a major new photography exhibition at the Royal National ENT and Eastman Dental Hospitals to highlight the achievements of deaf people.
-
Dr Patrick Murphy is a consultant clinical neuropsychologist at the National Hospital for Neurology and Neurosurgery.
-
Learn more about how UCLH celebrated Research Open Day this month.
